Literature DB >> 16680035

Apolipoprotein M--a novel player in high-density lipoprotein metabolism and atherosclerosis.

Björn Dahlbäck1, Lars B Nielsen.   

Abstract

PURPOSE OF REVIEW: Apolipoprotein M is a recently described apolipoprotein predominantly associated with high-density lipoprotein, but also found in chylomicrons, very low-density lipoproteins, and low-density lipoprotein. The purpose is to review recent information on the unusual structural properties of apolipoprotein M and its possible role in formation of pre-beta high-density lipoprotein and reverse cholesterol metabolism. RECENT
FINDINGS: Apolipoprotein M is a lipocalin having a coffee filter-like structure with a hydrophobic ligand-binding pocket. Mature apolipoprotein M retains its signal peptide, which serves as a hydrophobic anchor. In mice, silencing of expression in the liver with siRNA led to disappearance of pre-beta high-density lipoprotein and appearance of unusually large high-density lipoproteins. This suggests that apolipoprotein M is important for the formation of pre-beta high-density lipoprotein and reverse cholesterol transport. In accordance with this idea, hepatic overexpression of apolipoprotein M with an adenovirus in low-density lipoprotein-receptor deficient mice led to an approximately 70% reduction of atherosclerosis. In addition to the liver, apolipoprotein M is also expressed in the kidney. Kidney-derived apolipoprotein M binds to megalin, a member of the low-density lipoprotein-receptor family, which interacts with many lipocalins in renal tubuli. Apolipoprotein M is excreted in the urine of mice with a kidney-specific megalin deficiency but not in the urine of normal mice, suggesting megalin-mediated uptake of apolipoprotein M in the tubular epithelium of normal mice.
SUMMARY: Apolipoprotein M is a novel apolipoprotein with unusual structural features that appears to play important roles in high-density lipoprotein metabolism and prevention of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680035     DOI: 10.1097/01.mol.0000226122.10005.88

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  15 in total

1.  LRP5 and plasma cholesterol levels modulate the canonical Wnt pathway in peripheral blood leukocytes.

Authors:  Maria Borrell-Pages; July Carolina Romero; Lina Badimon
Journal:  Immunol Cell Biol       Date:  2015-04-07       Impact factor: 5.126

Review 2.  Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases.

Authors:  Nathalie Burg; Jane E Salmon; Timothy Hla
Journal:  Nat Rev Rheumatol       Date:  2022-05-04       Impact factor: 20.543

3.  Plasma apoM Levels and Progression to Kidney Dysfunction in Patients With Type 1 Diabetes.

Authors:  Nathaniel L Baker; Samar M Hammad; Kelly J Hunt; Andrea Semler; Richard L Klein; Maria F Lopes-Virella
Journal:  Diabetes       Date:  2022-08-01       Impact factor: 9.337

4.  Evaluation of Apolipoprotein M Serum Concentration as a Biomarker of HNF-1alpha MODY.

Authors:  Jan Skupien; Grzegorz Kepka; Sylwia Gorczynska-Kosiorz; Anna Gebska; Tomasz Klupa; Krzysztof Wanic; Natalia Nowak; Maciej Borowiec; Jacek Sieradzki; Maciej T Malecki
Journal:  Rev Diabet Stud       Date:  2008-02-10

5.  [Screening and verification of plasma biomarkers for stable angina pectoris: a differential proteomic analysis].

Authors:  An-Na Shen; Shui-Wang Hu; Jing Huang; De-Zhong Zheng; Zhao-Ting Hu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-10-20

6.  Apolipoprotein M gene (APOM) polymorphism modifies metabolic and disease traits in type 2 diabetes.

Authors:  Jun-Wei Zhou; Stephen K W Tsui; Maggie C Y Ng; Hua Geng; Sai-Kam Li; Wing-Yee So; Ronald C Ma; Ying Wang; Qian Tao; Zhen-Yu Chen; Juliana C N Chan; Yuan-Yuan Ho
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

7.  Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication.

Authors:  Jin-Gang Gu; Cheng-liang Zhu; Duo-zhi Cheng; Yan Xie; Fang Liu; Xin Zhou
Journal:  Lipids Health Dis       Date:  2011-08-29       Impact factor: 3.876

8.  A systematic analysis of human lipocalin family and its expression in esophageal carcinoma.

Authors:  Ze-Peng Du; Bing-Li Wu; Xuan Wu; Xuan-Hao Lin; Xiao-Yang Qiu; Xiao-Fen Zhan; Shao-Hong Wang; Jin-Hui Shen; Chun-Peng Zheng; Zhi-Yong Wu; Li-Yan Xu; Dong Wang; En-Min Li
Journal:  Sci Rep       Date:  2015-07-01       Impact factor: 4.379

Review 9.  Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL.

Authors:  Peiqiu Cao; Haitao Pan; Tiancun Xiao; Ting Zhou; Jiao Guo; Zhengquan Su
Journal:  Int J Mol Sci       Date:  2015-07-28       Impact factor: 5.923

10.  Decreased activities of apolipoprotein m promoter are associated with the susceptibility to coronary artery diseases.

Authors:  Lu Zheng; Guanghua Luo; Jun Zhang; Qinfeng Mu; Yuanping Shi; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Xiaoying Zhang; Ning Xu
Journal:  Int J Med Sci       Date:  2014-02-20       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.